forminet 500 mg tabletti, kalvopäällysteinen
stada arzneimittel ag - metformin hydrochloride - tabletti, kalvopäällysteinen - 500 mg - metformiini
segluromet
merck sharp & dohme b.v. - ertugliflozin l-pyroglutamic acid, metformin hydrochloride - diabetes mellitus, tyyppi 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - segluromet is indicated in adults aged 18 years and older with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control:in patients not adequately controlled on their maximally tolerated dose of metformin alonein patients on their maximally tolerated doses of metformin in addition to other medicinal products for the treatment of diabetesin patients already being treated with the combination of ertugliflozin and metformin as separate tablets.
metformin orion 500 mg depottabletti
orion corporation - metformini hydrochloridum - depottabletti - 500 mg - metformiini
metformin orion 750 mg depottabletti
orion corporation - metformini hydrochloridum - depottabletti - 750 mg - metformiini
metformin orion 1000 mg depottabletti
orion corporation - metformini hydrochloridum - depottabletti - 1000 mg - metformiini
metformin mylan 500 mg tabletti, kalvopäällysteinen
mylan ab - metformini hydrochloridum - tabletti, kalvopäällysteinen - 500 mg - metformiini
metformin mylan 850 mg tabletti, kalvopäällysteinen
mylan ab - metformini hydrochloridum - tabletti, kalvopäällysteinen - 850 mg - metformiini
metformin mylan 1000 mg tabletti, kalvopäällysteinen
mylan ab - metformini hydrochloridum - tabletti, kalvopäällysteinen - 1000 mg - metformiini
metformin sandoz 850 mg tabletti, kalvopäällysteinen
sandoz gmbh - metformini hydrochloridum - tabletti, kalvopäällysteinen - 850 mg - metformiini
metformin sandoz 500 mg tabletti, kalvopäällysteinen
sandoz gmbh - metformini hydrochloridum - tabletti, kalvopäällysteinen - 500 mg - metformiini